Lucentis (ranibizumab) | Patient Counseling & Communication

Lucentis (ranibizumab) | Patient Counseling & Communication

Lucentis (ranibizumab) | This course provides patient-facing counseling information while demonstrating patient counseling technique. It is intended for healthcare students and practitioners (pharmacy, nursing, medical, allied health) to improve patient counseling and patient communication skills. Counseling information includes: drug indications, dosing, and common side effects.

lucentis, ranibizumab, vascular endothelial growth factor inhibitor, VEGF, VEGF inhibitor, ophthalmology, monoclonal antibody, mab, macula, macular, macular damage, age-related macular degeneration, macular edema, diabetic retinopathy, myopic choroidal neovacularization

{{ course_length }} minutes
March 14, 2019
Introductory
Course Version: v1.0
Prescription Only
For Healthcare Professionals
Learning Path Inclusions: {{ learning_path_count }}
Premium Course

Save Course